Zusammenfassung
Hyperpigmentierungen der Haut wurden seit frühen Zeiten sowohl bei hellhäutigen Kaukasiern als auch bei dunkelhäutigen Populationen als Zeichen von Unreinheit angesehen. Sie gelten heute lediglich als ästhetisches Problem, und die betroffenen Personen versuchen, dunkle Hautflecken, die kosmetisch störend sind, mit unterschiedlichen Mitteln zu entfernen oder aufzuhellen. Neben chirurgischen Maßnahmen stellte sich hierbei die Bleichwirkung einiger extern auf die Haut aufgetragener Stoffe als hilfreich heraus. Hyperpigmentierungen können allerdings durch Melaninpigment, aber auch durch andere endogene Pigmentprodukte, hierunter vor allem Hämosiderin, und eine Vielzahl exogener Stoffe hervorgerufen werden (Tabelle 38–1).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Almond-Roesler B, Zouboulis CC (2000) Successful treatment of solar lentigines by brief gentle cryosurgery using a kryomed device. Br J Dermatol 143: 216–218
Baliña LM, Graupe (1991) The treatment of melasma. 20% azelaic acid versus 4% hydroquinone creme. Int J Dermatol 30:893–895
Benmaman O, Sanchez JL (1988) Treatment and camouflaging of pigmentary disorders. Clin Dermatol 6: 50–61
Bulengo-Ransby SM, Griffiths CEM, FFF Kimbrough-Green et al. (1993) Topical tretinoin (retinoic acid) therapy for hy-perpigmented lesions caused by inflammation of the skin in black patients. New Engl J Med 328:1438–1443
Day TW, Padue CC (1993) Preliminary experience with a flashlamp-pulsed tunable dye laser for treatment of benign pigmented lesions. Cutis 51:188–190
Ferguson J, Frain-Bell W (1989) Pigmentary disorders and systemic drug therapy. Clin Dermatol 7:44–54
Fitton A, Goa KL (1991) Azelaic acid. A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary disorders. Drugs 41:780–798
Griffiths CEM, Finkel LJ, Ditre CM et al. (1993) Topical tretinoin (retinoic acid) improves melasma. A vehicle-controlled, clinical trial. Br J Dermatol 129:415–421
Goldman MP, Weiss RA (2001) Treatment of poikiloderma of Civatte on the neck with an intense pulsed light source. Plast Reconstr Surg 107:1376–1381
Green D, Friedman KJ (2001) Treatment of minocycline-induced cutaneous pigmentation with the Q-switched Alexandrite laser and a review of the literture. J Am Acad Dermatol 44:342–347
Guevara IL, Pandya AG (2001) Melasma treated with hydrochinone, tretinoin and a fluorinated steroid. Int J Dermatol 40: 212–215
Haywood RM, Dovale M (1999) Treatment of poikiloderma of Vicatte with the pulsed dye laser: a series of seven cases. J Cutan Laser Ther 1:45–48
Hendrix JD, Greer KE (1992) Cutaneous hyperpigmentation caused by systemic drugs. Int J Dermatol 34:458–466
Herzberg IJ (1985) Therapie melaninbedingter Pigmentsanomalien. Hautarzt 36: 635–638
Hexsei DM, Mazzuco R, Bohn J et al. (2000) Clinical comparative study between cryotherapy and local dermabrasion for the treatment of solar lentigo on the back of the hands. Dermatol Surg 26: 457–462
Jimbow K (1991) N-acetyl-4-S-cysteaminylphenol as a new type of depigmenting agent for the treatment of melanoderma of patients with melasma. Arch Dermatol 127: 1528–1534
Jimbow M, Jimbow K (1989) Pigmentary disorders in oriental skin. Clin Dermatol 7:11–27
Kanwar AJ, Dhar S, Kaur S (1994) Treatment of melasma with potent topical corticosteroids. Dermatology 188:170
Kligman AM, Willis I (1975) A new formula for depigmenting human skin. Arch Dermatol 111:40–48
Lerner EA, Sober AJ (1988) Chemical and pharmacological agents that cause hyperpigmentation or hypopigmentation of the skin. Clin Dermatol 6:327–337
Nordlund JJ (1988) Postinflammatory hyperpigmentation. Clin Dermatol 6:185–192
Nordlund JJ (1992) The significance of depigmentation. Pigment Cell Res [Suppl 2]: 237–241
Olumide YM, Odunowo BD, Odiase AO (1991) Regional dermatosis in the African. Part I. Facial hypermelanosis. Int J Dermatol 30:186–189
Ortonne J-P (1990) Pigmentary changes of the ageing skin. Br J Dermatol 35: 21–28
Palumbo A, d’Ischia M, Misuraca G, Prota G (1992) Skin depigmentation by hydroquinone: a chemical and biochemical insight. Pigment Cell Res [Suppl 2]: 299–303
Stern RS, Dover JS, Levin JA et al. (1994) Laser therapy versus cryotherapy of lentigines. J Am Acad Dermatol 30: 985–987
Tafazzoli A, Rostan EF, Goldman MD (2000) Q-switched ruby laser treatment for sclerotherapy hyperpigmentation. Dermatol Surg 26: 653–656
Tan OT, Morelli JG, Kurban AK (1992) Pulsed dye laser treatment of benign cutaneous pigmented lesions. Lasers Surg Med 12:538–542
Taylor CR, Flotte TJ, Gange W et al. (1994) Treatment of nevus of Ota by Q-switched ruby laser. J Am Acad Dermatol 30:743–751
Todd MM, Rallis TM, Gerwels JW et al. (2000) A comparison of 3 lasers and liquid nitrogen in the treatment of solar lentigines: a randomized, controlled, comparative trial. Arch Dermatol 136: 841–846
Verallo-Rowell VM, Verallo V, Graupe K et al. (1989) Doubleblind comparison of azelaic acid and hydroquinone in the treatment of melasma. Acta Derm Venereol (Stockh) [Suppl 143]: 58–61
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Orfanos, C.E., Garbe, C. (2002). Hyperpigmentierungen. In: Blume-Peytavi, U., et al. Therapie der Hautkrankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56219-8_38
Download citation
DOI: https://doi.org/10.1007/978-3-642-56219-8_38
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62541-1
Online ISBN: 978-3-642-56219-8
eBook Packages: Springer Book Archive